CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-21 | SOON-SHIONG PATRICK Chairman and CEO | Option exercise | +1,851,500 | $2.20 | $4.1M | 20,040,750 |
| 2019-03-21 | SOON-SHIONG PATRICK Chairman and CEO | Other disposition · Warrant (right to buy) | −17,589,250 | 0 | ||
| 2019-03-21 | SOON-SHIONG PATRICK Chairman and CEO | Option exercise · Stock Option (right to buy) | −1,851,500 | 0 | ||
| 2018-11-29 | GORLIN STEVE Director | Sale | −138,349 | $1.65 | $228K | 0 |
| 2018-11-29 | GORLIN STEVE Director | Sale | −34,019 | $1.70 | $58K | 138,349 |
| 2018-11-28 | GORLIN STEVE Director | Sale | −17,140 | $1.76 | $30K | 172,368 |
| 2018-11-27 | GORLIN STEVE Director | Sale | −100,000 | $1.75 | $175K | 189,508 |
| 2018-11-23 | GORLIN STEVE Director | Sale | −9,312 | $2.01 | $19K | 289,508 |
| 2018-11-21 | GORLIN STEVE Director | Sale | −22,900 | $2.02 | $46K | 298,820 |
| 2018-11-14 | GORLIN STEVE Director | Sale | −115,930 | $2.21 | $256K | 0 |
| 2018-11-13 | GORLIN STEVE Director | Sale | −33,300 | $2.40 | $80K | 115,930 |
| 2018-11-12 | GORLIN STEVE Director | Sale | −47,050 | $2.43 | $114K | 149,230 |
| 2018-08-27 | Simon Barry J. See remarks | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2018-08-27 | Nelson Sonja Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2018-08-27 | GORLIN STEVE Director | Sale | −18,300 | $3.09 | $56K | 196,280 |
| 2018-08-24 | GORLIN STEVE Director | Sale | −10,225 | $3.07 | $31K | 214,580 |
| 2018-08-23 | GORLIN STEVE Director | Sale | −21,475 | $3.06 | $66K | 224,805 |
| 2018-08-02 | Nelson Sonja Chief Financial Officer | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2018-07-11 | SOON-SHIONG PATRICK Chairman and CEO | Option exercise | +9,257 | $1.62 | $15K | 40,565,814 |
| 2018-07-11 | SOON-SHIONG PATRICK Chairman and CEO | Option exercise · Warrant (right to buy) | −9,257 | 0 |
Page 19 of 22 · 433 trades